Ensysce Biosciences, Inc. (ENSC)
Pharmaceutical Preparations
Latest Price
$0.25
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.42
P/B Ratio
0.61
Institutional Ownership
5.2% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 149.7K | -- | 1.61% | -- | 2026-03-31 |
| PERCEPTIVE ADVISORS LLC | 86.7K | -- | 0.93% | -- | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 73.9K | -- | 0.80% | +51.8K | 2026-03-31 |
| CITADEL ADVISORS LLC | 57.4K | -- | 0.62% | +42.8K | 2026-03-31 |
| XTX Topco Ltd | 24.4K | -- | 0.26% | +13.4K | 2026-03-31 |
| VANGUARD FIDUCIARY TRUST CO | 23.9K | -- | 0.26% | -- | 2026-03-31 |
| JANE STREET GROUP, LLC | 13.6K | -- | 0.15% | -- | 2026-03-31 |
| Virtu Financial LLC | 13.3K | -- | 0.14% | -909 | 2026-03-31 |
| TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC | 13.0K | -- | 0.14% | +1.0K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 12.9K | -- | 0.14% | -- | 2026-03-31 |